Redox, Inc.

United States · www.redoxengine.com · 5 vendors

Resilience scores

Technology vendors

Services catalogue

1 service in catalogue across 1 category; runs on 5 sub-vendors.

Insights

Last updated 2026-07-09 · revision 2

5 direct vendors, 115 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 9/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Redox exhibits exceptionally high migration readiness due to its inherently cloud-native and multi-cloud architecture, with core products like 'EHR-to-Cloud Connectivity' designed to facilitate data movement to AWS, Azure, and GCP. This demonstrates a deep understanding and capability in cloud environments. The company's use of modern interoperability standards such as FHIR and REST APIs, alongside its focus on AI/ML data pipelines, positions it well for adopting new cloud services and technologies. Its existing stringent regulatory compliance (HIPAA, HITRUST, SOC 2 Type 2) means that migration efforts would not be hampered by the need to establish new compliance frameworks, as these are already integrated into its operations. Crucially, the reported 'Total Vendors: 0' for its own operations implies a minimal to non-existent vendor lock-in risk, providing immense flexibility and reducing the complexity and cost typically associated with migrating away from entrenched vendor solutions. The primary limitation in assessing migration readiness is the lack of information regarding financial stability (revenue concentration, growth history), which could impact the ability to fund large-scale migration initiatives. Additionally, specific data residency requirements are not specified, which could introduce complexities if future migrations involve international expansion or stricter data sovereignty regulations.

Compliance

9 in-scope frameworks identified; showing 3.

HITRUST CSF — Compliant

HITRUST CSF (Common Security Framework) is the de facto security certification standard for the US healthcare industry, combining requirements from HIPAA, NIST, ISO 27001, and other frameworks. Redox has achieved the highest level of HITRUST certification (r2), which is a rigorous third-party validated assessment. The risk level is Medium because: (1) HITRUST r2 certification must be renewed periodically (typically every two years with interim assessments); (2) the scope covers AWS and GCP environments but any expansion to new infrastructure would require re-certification; (3) HITRUST is not a legal mandate but is increasingly required by large health systems and payers as a vendor qualification criterion. The risk is not High because Redox has demonstrated active, current certification.

Evidence: https://www.redoxengine.com/platform-security/, https://www.redoxengine.com/, https://www.redoxengine.com/blog/six-critical-data-security-questions-you-should-ask-every-healthcare-technology-vendor

FTC Act — Assessment Required

The FTC Health Breach Notification Rule (16 CFR Part 318) was significantly expanded in 2023 to cover health apps and connected devices that are not covered by HIPAA. The FTC Act Section 5 (unfair or deceptive practices) also applies to all US companies. The risk level is Medium because: (1) Redox's core PHI processing is covered by HIPAA (not FTC Health Breach Notification Rule), but any non-HIPAA health data processing could trigger FTC jurisdiction; (2) the FTC has been increasingly active in health data privacy enforcement; (3) Redox's developer platform and API services may involve health data outside of traditional HIPAA-covered relationships; (4) the FTC's expanded interpretation of 'health breach notification' could apply to certain Redox use cases. Assessment is required to determine the precise scope of FTC obligations.

Evidence: https://www.redoxengine.com/legal/privacy-policy/, https://www.redoxengine.com/platform-security/

HITECH Act — Compliant

The Health Information Technology for Economic and Clinical Health (HITECH) Act strengthened HIPAA enforcement and extended HIPAA obligations directly to Business Associates. Redox is a Business Associate under HIPAA/HITECH, making HITECH directly applicable. The risk level is High because: (1) HITECH significantly increased HIPAA penalties (up to $1.9M per violation category per year); (2) HITECH requires Business Associates to comply directly with HIPAA Security Rule safeguards; (3) Redox processes PHI at massive scale (20B+ transactions/year), amplifying the potential impact of any breach; (4) HITECH's breach notification requirements apply directly to Redox as a Business Associate. The risk is mitigated by Redox's HITRUST r2 certification and active compliance program.

Evidence: https://www.redoxengine.com/platform-security/, https://www.redoxengine.com/

Financials

Three-year financials

Financial Resilience Score: 6/10

Redox, Inc. is a private, venture-backed US healthcare data interoperability company that does not publish audited financial statements, making direct assessment of liquidity, profitability, or leverage impossible from primary sources. However, qualitative signals suggest moderate resilience: the company holds a strong market position in a durable niche with meaningful network effects (12,200+ connected organizations, 14,900+ live integrations, 109B+ cumulative messages processed), and benefits from regulatory tailwinds including ONC information-blocking rules, TEFCA, CMS interoperability mandates, and payer FHIR requirements. The company has raised approximately $95-100M in disclosed venture funding through a Series D (~$45M) in early 2021, led by Adams Street Partners. However, no new priced round has been publicly announced since 2021, which in the post-2022 digital-health venture down-cycle raises concerns about down-round risk or the need to prioritize cash-flow break-even. Two rounds of layoffs (2022 and 2023, cumulatively estimated at ~20-25% of staff per trade press) suggest management has shifted toward efficiency. Positive signals include continued growth in usage metrics (transactions, connected organizations) even without new funding, preferred cloud-partner relationships (AWS, Azure, GCP, Databricks, Snowflake), and strong compliance posture (HITRUST r2, SOC 2 Type 2). Risk factors include customer concentration in venture-backed digital-health startups (some of which have contracted or failed since 2022), competitive pressure from EHR-native APIs and open FHIR endpoints, and concentration on US healthcare regulation with minimal international diversification.

Key strengths: Category leadership in US healthcare interoperability with strong network effects, Large installed base: 12,200+ connected organizations and 14,900+ live integrations, Regulatory tailwinds from ONC, TEFCA, CMS interoperability mandates, and payer FHIR requirements, Preferred cloud-marketplace relationships with AWS, Azure, GCP, Databricks, Snowflake, Strong compliance posture: HITRUST r2 certified and SOC 2 Type 2 maintained, ~$95-100M in total disclosed venture funding raised, Continued growth in usage metrics despite absence of new funding rounds

Risk factors: No public financial statements; limited transparency for external stakeholders, No new priced funding round announced since Series D in early 2021, Two rounds of layoffs (2022 and 2023) totaling an estimated ~20-25% of staff, Customer concentration in venture-backed digital-health startups vulnerable to market contraction, Competitive pressure from EHR-native APIs (Epic, Oracle Health/Cerner) and free FHIR endpoints, Concentration on US healthcare market with minimal international diversification, Potential down-round risk given peak-market 2021 valuation

Revenue by geography

Workforce by country

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report